Prevalence and metabolic control in adult patients with autoimmune thyroid disease and type 1 diabetes mellitus
周泳雯,严晋华,郑雪瑛,骆斯慧,凌萍,吴泽开,刘宏霞,甘露,沈玄韬,杨黛稚,姚斌,翁建平
DOI: https://doi.org/10.3760/cma.j.cn115791-20191023-00383
2020-01-01
Abstract:Objective:To investigate the prevalence of the autoimmune thyroid disease (AITD) and the metabolic control in adult patients with type 1 diabetes mellitus (T1DM).Methods:A total of 1 158 adult patients (≥18 years; male/female, 524/634) registered in the Guangdong T1DM Translational Study from June 2011 to November 2018 were selected into the analysis, with 982 patients in T1DM only group and 176 patients in comorbid AITD group. According to thyroid function at enrollment, patients with comorbid AITD were further divided into hyperthyroidism group (
n=42), hypothyroidism group (
n=31) and normal thyroid function group (
n=103). Biochemical information such as glycated hemoglobin A
1c(HbA
1c), body mass index (BMI), thyroid stimulating hormone (TSH) were collected at enrollment and one-year follow-up. Changes of indexs at one-year follow up were further analyzed between groups. Statistical analysis was performed using
t test, Mann-Whitney
U or chi-square test.
Results:At onset, patients with comorbid AITD presented more serious metabolic disorder. After one-year follow-up, both groups showed significant reduction in HbA
1c ［AITD group: 8.40% (7.03%, 10.78%) vs 7.65% (6.60%, 8.93%),
P<0.01; T1DM group: 8.50% (7.20%, 10.80%) vs 7.75% (6.70%, 9.10%),
P<0.01］ and higher BMI, ln glucose disposal rate compared with baseline. However, between-groupdifferences were not significant (both
P>0.05). After one-year follow-up, TSH level was still lower in hyperthyroidism group compared with normal thyroid function group ［0.15 (0.01, 0.39) vs 1.92 (1.34， 3.17) nmol/L,
P<0.05］. Instead of the significant improvement on HbA
1c level in hypothyroidism group and normal thyroid function group, there was no difference in hyperthyroidism group. Moreover, compared with normal thyroid function subgroup, there was significantly higher BMI ［(22.37±2.89) vs (20.71±2.77) kg/m
2,
P<0.05］ and systolic/diastolic blood pressure in hypothyroidism subgroup ［systolic blood pressure: 120 (110, 129) vs 111 (103, 122) mmHg；diastolic blood pressure: 78 (75, 81) vs 70 (63, 77) mmHg, 1 mmHg=0.133 kPa, both
P<0.05］.
Conclusion:Metabolic disorder was more serious in adult T1DM patients with AITD. After one-year follow-up, there was no significant improvement on glycemic control in T1DM patients with AITD and hyperthyroidism, and those with hypothyroidism were easier to have higher BMI and blood pressure.